Dr.Washer Response_Cynata Deals, page-2

First 2 Last

Share
Profile

Follow
dstambou

200 Posts.

23/03/15

15:02

Post #: 14962689
Share

Originally posted by TheArchitect ↑

I have conversed with Dr. Stewart Washer and Dr. Ross Macdonald through email and received some great responses from them, I will post one of the email responses from Dr. Washer that I received this afternoon, which I have permission to post onto public forums.

"...In terms of the recent article, there is indeed great potential with Cynata and we have a well defined pathway that we are progressing that is not really clear in the article.

Cynata has the only technology that enables unlimited production of quality stem cells (MSC) from a single, one time donor. We have now proven this works in the pilot manufacturing run as announced. This has generated a good deal of interest from potential partners (commercial and research/academic) and the broader scientific community. The fact that the Cynata technology came from the leaders in stem cell research at Uni Wisconsin (Thompson and Slukvin) has given us a great pedigree base.

We are now speaking to a number of parties and hope to have partnership deals completed and announced in 2015. This should impact very positively on our share price form this relatively small current valuation.

Remember that MSB increased around 10X on the back of the Cephalon partnership deal from around $200m to around $2bn. They are indeed a good indicator for the potential in stem cell medicine with a number of indications in late stage clinical trials.

Thanks for your shareholding and support, I think we should see a good 2015 for our company !

Best Regards

Stewart..."

I think this is a great response from Dr.Washer and was good to get some reassurances from the company in their future plans. Buy up while it's cheap, this won't stay low for long in my opinion.

(The above is in no way financial advice, always do your own research before making a financial investment)

TheArchitect

Expand

Market not agreeing with the board currently. Will drop about 10% today, I anticipate. A "hope" is perhaps too remote, for now !

CYP Price at posting: 87.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SFX

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

NXM

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

NIM

Nimy extends sulphide targets at Mons with new anomalies identified

There are more pages in this discussion • 67 more messages in this thread...

First 2 Last

Add CYP (ASX) to my watchlist

(20min delay)
Last 28.0¢		Change 0.000(0.00%)		Mkt cap ! $50.29M

Open	High	Low	Value	Volume
27.0¢	28.0¢	27.0¢	$671	2.476K

Buyers (Bids)

No.	Vol.	Price($)
3	20351	27.0¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	3306	1

View Market Depth

No.	Vol.	Price($)
3	20351	0.270
1	9931	0.265
2	127000	0.260
1	8000	0.245
3	125942	0.240

Price($)	Vol.	No.
0.280	3306	1
0.285	5000	1
0.290	16480	1
0.295	10160	1
0.300	30000	1

Last trade - 14.25pm 27/06/2024 (20 minute delay)

CYP (ASX) Chart

Dr.Washer Response_Cynata Deals, page-2

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Nimy extends sulphide targets at Mons with new anomalies identified

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Dr.Washer Response_Cynata Deals, page-2

Top Stories

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Nimy extends sulphide targets at Mons with new anomalies identified

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News